Milophene 50 MG tab 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR9BK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,646
Award facts
- Contract value 100% obligated
- $25,645.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,645.55 to AmerisourceBergen Drug Corp for the supply of Milophene 50 mg tablets (30-count units) with a firm fixed-price structure. This is a non-set-aside award executed on January 30, 2026, with an ultimate completion date of February 2, 2026. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 31, 2031, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement to fulfill this pharmaceutical supply requirement for the Defense Logistics Agency's Medical Supply Chain. The company maintains a significant presence as a federal contractor, demonstrating extensive capability in delivering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to military treatment facilities and other government healthcare systems. This delivery order represents a routine pharmaceutical procurement within the company's established federal contracting relationship with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FR9BK?
SPE2DR26FR9BK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FR9BK worth?
The government has obligated $25,646 on SPE2DR26FR9BK.
Is contract SPE2DR26FR9BK an order under another contract?
Yes. SPE2DR26FR9BK is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR9BK competed?
The extent of competition for SPE2DR26FR9BK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award